Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to...
Q1 2026
May 13, 2026
FY 2025
Mar 19, 2026
Q4 2025
Q3 2025
Nov 14, 2025
Q2 2025
Aug 14, 2025